Medication-related osteonecrosis of the jaws and quality of life: review and structured analysis
- 1 April 2020
- journal article
- review article
- Published by Elsevier BV in British Journal of Oral and Maxillofacial Surgery
- Vol. 58 (6), 619-624
- https://doi.org/10.1016/j.bjoms.2020.03.010
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Treatment of Medication-Related Osteonecrosis of the Jaw and its Impact on a Patient’s Quality of Life: A Single-Center, 10-Year Experience from Southern ItalyDrug Safety, 2017
- Quality of life considerations in head and neck cancer: United Kingdom National Multidisciplinary GuidelinesThe Journal of Laryngology & Otology, 2016
- The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk FactorsOral and Maxillofacial Surgery Clinics of North America, 2015
- United Kingdom nationwide study of avascular necrosis of the jaws including bisphosphonate-related necrosisBritish Journal of Oral and Maxillofacial Surgery, 2015
- American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 UpdateJournal of Oral and Maxillofacial Surgery, 2014
- Non-complex reconstructive techniques in the management of BRONJ: a case series of patient-related outcomesOral and Maxillofacial Surgery, 2014
- Osteonecrosis of the Jaw and Oral Health–Related Quality of Life After Adjuvant Zoledronic Acid: An Adjuvant Zoledronic Acid to Reduce Recurrence Trial Subprotocol (BIG01/04)Journal of Clinical Oncology, 2013
- What Is the Role of Hyperbaric Oxygen in the Management of Bisphosphonate-Related Osteonecrosis of the Jaw: A Randomized Controlled Trial of Hyperbaric Oxygen as an Adjunct to Surgery and AntibioticsJournal of Oral and Maxillofacial Surgery, 2012
- Quality of Life Implications of Bisphosphonate-Associated Osteonecrosis of the JawThe Oncologist, 2011